NEJM· @NEJM · X·· 21 小时前精选AI 评分58
AI 导读
NEJM公布的PEPPER试验结果显示,在髋或膝关节置换术后静脉血栓栓塞症(VTE)预防中,阿司匹林对利伐沙班或华法林在症状性VTE或死亡方面未达非劣效。同时,华法林和利伐沙班在安全性方面对阿司匹林也未达非劣效。完整结果与研究摘要见 https://nej.md/4iIxVL0。
推荐理由
PEPPER试验同时检验疗效与安全性非劣效,结果提示阿司匹林与抗凝药在髋膝关节置换术后VTE预防中各有短板。
正文
A trial of venous thromboembolism (VTE) prophylaxis after hip or knee arthroplasty did not show that aspirin was noninferior to rivaroxaban or warfarin for symptomatic VTE or death. Warfarin and rivaroxaban were not noninferior to aspirin for safety. Full PEPPER trial results and Research Summary: https://nej.md/4iIxVL0
来源:NEJM · x.com